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Abstract
Major depressive disorder is one of the most common and burdensome
psychiatric disorders. Many individuals still experience symptoms despite
pharmacological treatment. Breathing techniques have shown potential for stress,
depression, and anxiety reduction. A second promising treatment are mindfulness-based
interventions, which have been shown to effectively decrease depression with fewer side
effects than pharmacological agents. Both interventions are accessible via remote
instruction. This study will investigate the effect of Sudarshan Kriya Yoga breathwork on
depression symptoms. Using a prospective, randomized controlled trial, subjects will
receive Sudarshan Kriya Yoga, Mindfulness Based Stress Reduction, or standard care for
8-weeks. We will measure changes in depressive symptoms using two validated
depression inventories and will examine their effects on selected brain regions using
resting-state functional magnetic resonance imaging. These results may guide an
integrative approach for depression, expanding current options through a low-cost, lowrisk, and accessible behavioral intervention adjunctive to concurrent pharmacological
treatment.

vi

CHAPTER 1: INTRODUCTION
1.1 Background
1.1.1 Depression Epidemiology and Recurrence
To date, more than 264 million people suffer from major depressive disorder
(MDD), accounting for 22.8% of the global burden of disease.1 MDD is pervasive across
age groups, ethnicities and socioeconomic statuses.2 Beyond the potential to be disabling
psychologically, depression is associated with reduced quality of life, greater health
comorbidities, and excess mortality.3,4 Further, there is a high likelihood of depression
recurrence following completion of traditional pharmacological approaches.5
1.1.2 Clinical Definition and Diagnostic Criteria
MDD is clinically defined in patients with a history of at least one major
depressive episode without mania or hypomania. According to the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V), a major depressive
episode consists of five or more of the following symptoms, one of which must be either
depressed mood or anhedonia: insomnia or hypersomnia, appetite decrease or increase,
unintentional weight loss or gain, psychomotor retardation or agitation, fatigue, poor
concentration, excessive thoughts of worthlessness or guilt, and recurrent thoughts
concerning death or suicide.6 The symptoms must all be present within the same twoweek period and reflect a significant change from prior baseline functioning. Lastly, the
diagnosis of MDD is reached when excluding other disorders such as delusional disorder
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or schizophrenia, and the symptoms must cause a significant impairment in social,
occupational, or other areas of functioning.
1.1.3 Depression: Goals of Treatment & Initial Treatment Options
When considering the goals of treatment, it is important to distinguish two
concepts: response and remission. Based on a clinician rated depression scale, response is
considered improvement  50% from baseline depression rating score, while remission is
achieved once the overall depressive syndrome is concluded. Initial treatment aims for
complete depressive symptom remission and return to baseline functioning.7,8
While both psychotherapy and pharmacotherapy are validated options for
treatment, most often antidepressants are chosen as first line management for MDD.9-12
Selective Serotonin Reuptake Inhibitors (SSRIs) predominate and are the most widely
prescribed class of antidepressants.9,13 One reason for their frequent implementation is
that antidepressants have been shown to be effective in multiple meta-analyses of
randomized controlled trials over years of research14-17 and thus accepted into practice
guidelines.18,19 From a patient perspective, contributing factors such as cost,
comorbidities, and psychosocial stressors must be taken into account when considering
these two treatment options.
Although over a thousand randomized clinical trials have been conducted with
antidepressants, there are concerns regarding comprehensive study design elements and
antidepressant efficacy, safety and tolerability.20 Improper interpretation of statistical
significance, publication bias21, manipulated study design, selection bias of study
populations, short term follow-up which excludes discussion of potential long term
adverse effects, and focus on clinically non-relevant outcomes have the potential to
2

construct a false sense of security regarding antidepressant effectiveness and tolerability.
Furthermore, SSRIs have side effects such as sexual dysfunction, lethargy, drowsiness,
nausea, weight gain and alteration of normal sleep pattern which reduce compliances.22
Conversely, the antidepressant can be changed to a different class, which prolongs the
time for the new drug to reach effectiveness and thus the amount of time it takes for the
patient to achieve response and remission.
Patients may discontinue their antidepressants suddenly following remission
which carries a risk of relapse and discontinuation syndrome.23 These withdrawal effects
may appear within hours to days after cessation, and include dizziness, gastrointestinal
complaints, lethargy, flu-like symptoms, irritability and anxiety.24 By extension, these
distressing symptoms may result in unnecessary and costly testing if not recognized as
symptoms of discontinuation.25 These findings illustrate the necessity of exploring
whether we can supplement antidepressant pharmacological therapy in order to improve
antidepressant response, limited adverse effects, and achieve remission.
1.1.4 Introduction to Sudarshan Kriya Yoga
Sudarshan Kriya Yoga (SKY) is a type of yogic breathwork consisting of three
types of breath: ujjayi, bhastrika, and Sudarshan Kriya, in addition to a brief chanting
component.26 There is a rest period of approximately 20 seconds following each of the
four stages of breathing. Ujjayi, also called “victorious breath”, consists of 2-4 cycles per
minute (cpm) of nostril breathing with a slight constriction of the laryngeal muscles to
produce a shallow, ocean-like sound when breathing. Each cycle consists of 4 count
inspiration, 4 count end-inspiration hold, 6 count expiration, and 2 count expiration hold,
complemented with hand placement on the lower belly, ribs or upper back. The second
3

component called Bhastrika or bellows breathing is a forceful technique where air is
actively inhaled and exhaled with the use of abdominal muscles at approximately 15-20
cpm. Next, participants typically chant the word “om” three times on a long exhale with a
15 second rest period after each chant. The last breathing component of SKY is
Sudarshan Kriya, which unlike the first component has no end expiration or end
inhalation breath holding. Inhalation and exhalation phases are equal in duration and no
airway resistance is used, unlike ujjayi. Sudarshan Kriya has three different rates of
breathing: slow (8-14 cycles per minute, cpm), medium (30 cpm) and rapid (150-180
cpm) (See Appendix A). The number of breaths and duration of cycles differ between in
class sessions and at home individual practice. This session typically closes with kriya, a
slow, steady set of 8-10 slow cycles with a 5-minute period of rest in the supine position
to prevent dizziness and lightheadedness when standing up.
Different types of yoga incorporate mindfulness meditations, breathwork and
physical postures or asanas. The protocol for SKY in our proposed study will not require
physical movement, which makes it accessible to most ability levels. SKY has been
utilized as an intervention for anxiety, stress and depression.26 The exact mechanism
through which breathwork achieves beneficial effects is unknown, but some studies
highlight its influence on cardiovascular parameters, autonomic variability, and
cerebrovascular hemodynamics.27-29 SKY holds promise as an adjunctive treatment
option for MDD given its ease of use, accessibility, lack of adverse effects, as well as
potential long-term benefits even after concluding the intervention.
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1.1.5 Introduction to Mindfulness Based Stress Reduction
A widely accepted operational definition of mindfulness-based interventions
(MBIs) consists of two core concepts. Self-regulation of attention on the current moment
complements an overall view of openness and acceptance regarding the present moment
which includes any intrusive or distressing thoughts, emotions or memories.30 Attention
is self-regulated and maintained in a non-ruminating and nonreactive way, which is
beneficial for the depressed patient population, as rumination is a prevalent symptom.
Mindfulness Based Stress Reduction (MBSR) was the first MBI to gain empirical
support.31 The three components of MBSR are full body scan, sitting meditation, and
Hatha yoga. The combination of mental and physiologic components promote stability of
mood, lessen reflexive rumination, and potentially extend periods of depressive remission
in a depressed patient population.32,33
1.1.6 Introduction to the Default Mode Network
The default mode network (DMN) is an interconnected neurological circuit shown
to be active during times of self-referential thought and non-task-based states.34 It is made
up of discrete areas of the brain: a central midline core made of the posterior cingulate
cortex (PCC) and the medial prefrontal cortex (mPFC) which communicates with two
subnetworks: the dorsal medial prefrontal cortex (dMPFC) subsystem and the medial
temporal lobe (MTL) subsystem.35 The DMN has also been associated with selfreflection on one’s own emotional state, which would support its relationship with
psychological disorders and over time with depressive rumination.36,37 The DMN is the
brain’s intrinsic, ongoing activity that is active when participants are not focused on the
outside world, such as mind wandering.38 The DMN has been an area of interest in
5

depression because depressive, self-focused thoughts may correlate with the baseline
within-network DMN hyperconnectivity that is uniquely seen in depressed patients. 39
1.2 Statement of the Problem
MDD is a disabling disease typically treated with pharmacological therapy which
has modest short-term benefit and variable long-term effectiveness. Despite use of first
line pharmacotherapy, many individuals still suffer from depressive episode recurrence
and do not achieve remission. There is a clear need for interventions beyond
pharmacology, including further validation of Mindfulness-Based Interventions such as
Mindfulness Based Stress Reduction, and other non-pharmacological interventions.
Sudarshan Kriya Yoga, with its emphasis on breathwork, has the potential for
effectiveness as an adjunct therapy to antidepressants. Behavioral adjuncts may help to
prevent escalation to high intensity therapies (such as one to one psychological therapies)
and avoid further financial, emotional, and psychological burden within the patient
population.
1.3 Goals and Objectives
The primary aim of this study is to evaluate the antidepressant effectiveness of
Sudarshan Kriya Yoga as adjunctive treatment for MDD in comparison to Mindfulness
Based Stress Reduction and solely pharmacologic treatment. The secondary aim is to
investigate potential change in functional connectivity within the DMN in mild to
moderately depressed patients on stable pharmacological therapy who receive SKY or
MBDR as adjuvant therapies.
6

1.4 Hypothesis
In this study, it is hypothesized that there will be a statistically significant
difference in depressive symptoms in subjects aged 18-65 years old with mild to
moderate depression on stable antidepressant pharmacological therapy following an 8week SKY intervention as adjunctive treatment, as measured through the 17item
Hamilton Depression Rating Scale (HAM-D17)40 (see Appendix B) and Beck Depression
Inventory, Second Edition (BDI-II)41 (See Appendix C) compared to a group using
MBSR as adjunctive treatment alongside pharmacologic therapy, and a third group
continuing their pharmacological treatment only.
To address the second aim, it is hypothesized that resting state functional
connectivity MRI (rsfcMRI) scans will show a change in DMN functional connectivity
(FC) as measured through BOLD signal changes when comparing baseline imaging
obtained prior to SKY intervention to imaging acquired post-intervention. Definitely need
to define DMN in a background section or reader will no know what this means.
1.5 Definitions
Resting state (fMRI scanning condition): the participant is not performing a task or
responding to a stimulus. Instead, he/she will be awake but with eyes closed, not thinking
about anything in particular.
Functional connectivity: temporal associations of synchronous neural activity between
anatomically separate brain regions either at rest or during a task
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CHAPTER 2: LITERATURE REVIEW
2.1 Introduction
2.1.1 Literature Search
A thorough literature search was conducted by means of PubMed, Scopus, and
The Cochrane Library from December 2020-July 2021. Studies, meta-analyses, and
reviews relevant to the proposed study were initially based on perusing titles and
abstracts. A final search was completed on July 6, 2021. Key terms used in each data base
pertinent to the psychological disorder of depression included major depression, MDD,
major depressive disorder, unipolar depression, depressive disorder, depression, and
depressive. Studies utilizing yogic breathwork were also searched for by alternating terms
such as pranayama, Sudarshan Kriya Yoga, SKY, breathwork, controlled breathing, and
yoga(ic) breathing. Terms used to identify papers based on mindfulness interventions
included mindfulness, mindful, meditation, mindfulness-based intervention, MBI, MBSR,
mindfulness-based stress reduction, and stress reduction. Lastly, alternative terms for the
default mode network included resting state network, DMN, default network, resting
state, resting state connectivity, functional connectivity, and functional brain network.
We also used terms relevant to the anatomical aspects of the default mode network such
as posterior cingulate cortex, PCC, cingulate cortex, medial prefrontal cortex, and
prefrontal cortex. The aforementioned search terms were used in various combinations,
combining categories using and/or functionalities.
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Literature returned from the initial search (n=374) included prospective studies,
retrospective studies, clinical trials, randomized controlled trials, meta analyses and
systematic reviews. International studies were included in the review, but the search was
limited to the English language only. We also used articles from reference lists of the
studies that were selected after our initial search.
2.2 Sudarshan Kriya Yoga and Mindfulness Based Stress Reduction
2.2.1 Sudarshan Kriya Yoga Interventions in Depression
Sudarshan Kriya Yoga (SKY) has been shown to lessen the severity of stress,
anxiety, and depression. A prospective, randomized controlled trial (RCT) focused on
severe depression fulfilling DSM-IV criteria and had three distinct treatment arms: a 30
minute SKY session once a day versus imipramine versus bilateral electroconvulsive
therapy (ECT) three times per week.1 In order to isolate the effect of SKY breathwork,
only the three breathwork phases- ujjayi, bhastrika and Sudarshan Kriya- were taught
without mindful or relaxation techniques. The SKY arm showed a statistically significant
67% remission rate (defined as having a Hamilton Depression Rating Scale total score <
7), which is particularly impressive given the severity of the patients’ depression. At the
end of 4 weeks, SKY was superior to imipramine therapy and did result in lower
depression symptom severity.
A majority of studies taught SKY comprehensively using breathwork with guided
meditation and stress relieving skills. An intervention program in the United Kingdom
recruited individuals with mild to moderate depression and anxiety disorders who were
taught in four weekly, one-hour sessions with a certified SKY instructor.2 Intention to
12

treat analysis showed a statistically significant reduction in self-reported depression
symptoms by 22% and reduction in anxiety by 30% (p<0.001). All statistically significant
differences remained when performing subgroup analysis based on age groups, males
versus females, and medication use. Another clinical trial utilized SKY breathwork with
chanting in addition to weekly self-help groups and mindfulness tactics for 6 months in
subjects with a primary DSM-IV diagnosis of a Mood disorder, including depression.3 In
the depressed population, patients with and without antidepressant use both showed very
low to absent depression symptoms following completion based on the clinician rated
Hamilton Rating Scale for Depression (HAM-D 17) and patient completed Zung SelfRating Scale for Depression. The use of antidepressant medications did not seem to
significantly affect scores, which limited possible confounders. Given that medicated
subjects included in Group 1 were on the same dose for the past 6 months, the
medication’s effect reached a steady plateau. Thus, SKY could be seen as the compelling
factor that propelled improvement in depression which remained at 6 month follow-up.
A randomized waitlist-controlled trial utilized an 8-week intervention of SKY
breathwork with yoga, mindfulness meditation, and stress education in treatment resistant
major depressive disorder (MDD) patients.4 Treatment resistance was defined as
persistence of a non-psychotic, depressive episode despite  8 weeks of antidepressants.
Intention to treat (ITT) analysis showed that participants had an average reduction in
HAM-D17 total score of 9.77, which improved more than waitlist control (0.50). The
study had high completion rate at 77% despite significant time requirement with many
patients having school or work commitments during the day. To the researcher’s
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knowledge, this was the first study to show SKY as an effective and highly tolerable
adjuvant measure for treatment resistant depressed patients.
2.2.2 Mindfulness Based Interventions in Depression
It is thought that practices which center around mindfulness, termed mindfulnessbased interventions (MBIs), alleviate intense emotional states such as cyclical rumination
common in depression.5 Clinically applied MBIs within the field of mental health include
Kabat-Zinn’s mindfulness-based stress reduction (MBSR) and mindfulness-based
cognitive therapy (MBCT). In a meta-analysis of MBIs for psychiatric disorders, it was
found that MBIs were superior to no treatment and were equivalent to evidence-based
treatments such as antidepressants.6
A different meta-analysis evaluated twelve RCTs (n=578) utilizing MBIs such as
MBSR for participants meeting DSM-IV criteria for MDD or an anxiety disorder
compared to waitlist and active controls.7 All studies had a primary outcome of change in
symptom severity, measured through self-report and clinician rated questionnaires
including the HAM-D17. Random effects models showed that there was a postintervention between-group difference in favor of MBIs on primary symptom severity
with a medium effect size that was statistically significant (p < 0.01). Effects of MBIs on
depression symptom severity replicated findings of a previous meta-analysis.8
One of the most comprehensive reviews analyzed 209 trials of MBIs among
12,145 patients with varying psychological disorders, ages, and genders.9 This metaanalysis concluded that MBIs were more effective in lessening the severity of both
psychological and physical symptoms when compared to waitlist, psychoeducation,
supportive psychotherapy relaxation training and imagery, and suppression techniques.
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When analyzing the selected studies that targeted depression, the mean effect size on
depression was moderately strong for 5 pre-post studies and moderate for 8 waitlistcontrolled studies. Patients with baseline mild to severe depression all showed reduction
of depression severity to mild and moderate levels respectively post-treatment based on
the BDI-I and BDI-II. Treatment effects remained stable over follow-up periods ranging
from 3 weeks to 3 years. These findings mirror those of a prior meta-analysis8, which
concluded that mindfulness-based therapies showed a clinically significant large effect
sizes that maintained through a period of follow up.
A one-month long RCT used somatic relaxation training as an active control
comparing the effects of mindfulness meditation (MM) modeled on MBSR protocol.10 It
was hypothesized that both MBSR and somatic relaxation training would be beneficial in
reducing overall stress, but only the mindfulness intervention would reduce distracting
and ruminative thoughts. This study was included within our literature review because
rumination is a key symptom in depression. The protocol did match MBSR in its use of
body scan, sitting meditation, and Hatha yoga. At the conclusion of the study, unique to
only the MM group was the significant pre-post decreases in both distractive and
ruminative thoughts/behaviors based on the Daily Emotion Report, a self-report
questionnaire. Thus, the MM based on MBSR showed a unique ability to lessen
rumination and distraction, common symptoms of depression.
2.3 Feasibility and Efficacy of Internet Based Interventions
In light of the current COVID-19 pandemic with understandable social distancing
and restrictions in sizes of gatherings, technology may be the greatest ally in continuing
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mindfulness-based interventions. In the place of face-to-face MBIs, clear direction and
insight can still be achieved through the use of computer, smart phone, or tablet-based
interfaces and remote, online programming. Furthermore, it is adaptable to both
individual therapy and group therapy without posing a health risk.11
The proposed study’s focus on depressed individuals is pertinent as well. COVID19 can have emotional, mental and physical health consequences as it interrupts daily
living.12 A population-representative survey study showed that the prevalence of
depression had increased more than three-fold during the pandemic. Furthermore, more
severe depressive episodes during this pandemic may elevate drop-out rates from
treatment secondary to significant loss of motivation and debilitating apathy common in
depression, leading to inconsistent attendance.
Of note, the same survey showed that lower income during COVID-19 was
associated with a greater risk of depression, showing the disproportionate effect when
having less than $5000 in savings account was correlated with a 1.5 fold increased odds
of depressive symptoms, or 50% greater risk. As a result, resource limited communities
are a key patient population to evaluate. And yet, they may be excluded from in person
studies due to factors related to health disparity such as work schedules, child care, and
transportation costs. Therefore, it is more likely that in-person studies automatically
exclude large segments of the population. As a result, incorporation of internet-based
interventions may strengthen outreach and incorporation of those vulnerable patient
populations.
In one meta-analysis of 15 RCTs studying the relationship of online MBIs with
measures of mental health and well-being, online MBIs including MBSR had a beneficial
16

effect on depression, anxiety, mindfulness and well-being.13 This meta-analysis was the
first to show that online MBIs strengthened aspects that pertain to greater quality of life,
including well-being and mindfulness with a significant small effect size. A randomized
control pilot study utilized an internet-based mindfulness program over 8 weeks to
improve stress in adults without psychological disorders.14 Researchers adapted strategies
from MBSR, including body scan, mindfulness meditation, and sitting meditation.
Individuals who completed the mindfulness meditation course had a mean Perceived
Stress Scale score of 14.44 (5.86) compared to a mean score 23.73 (9.95) at the
beginning of the course, which was a statistically significant change (p<0.001) that
remained at 1-month follow-up. The pre-post effect size was 1.57, which is higher than
face-to-face MBSR and cognitive therapy courses ranging from 0.52 to 1.19 as
mentioned within the study. While limitations include lack of a control group and lack of
assessment of anxiety and depressive symptoms specifically, this study showed that
online mindfulness courses seem to achieve similar results to face-to-face therapies.
Another RCT evaluated the efficacy of unguided internet-based mindfulness
treatment for anxiety disorders.15 The mindfulness treatment group protocol consisted of
96 audio modules centered on sitting meditation, body scan, and mindfulness movement
to be performed 6 days per week for 8 weeks. This was compared to an online discussion
forum control group. Intention to treat (ITT) analysis showed that the mindfulness group
had a larger improvement in anxiety and depressive symptoms as well as insomnia from
baseline to after intervention. The BDI-II showed improvement in the mindfulness group
more so than the control group. When considering the implementation of internet-based
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mindfulness therapies in both clinical and nonclinical populations, there is support for
efficacy and feasibility of internet-based mindfulness therapies to improve mental health.

2.4 Depression and the Default Mode Network

2.4.1 The Neurobiology of Depression
Depressed individuals tend to focus most of their attention on negative stimuli and
excessively ruminate.16 The cognitive model of depression states that depressive
symptoms arise from and are sustained by maladaptive thinking processes such as
attention bias and dysfunctional attitudes. The neurobiological model of depression
coordinates these cognitive maladaptations with brain functional connectivity and
anatomy.17 These brain regions can be identified at baseline using fMRI, which also has
the potential to assess treatment outcomes and effects in various trials.18
Seeking to understand the affective aspects of self, researchers had healthy
subjects judge a series of personality traits and how that described themselves from “not
at all like me” to “very much like me” on a 4 point Likert scale.19 A voxel-wise analysis
of variance (ANOVA) between valence of traits and relevance of rating showed that both
the mPFC and posterior cingulate cortex (PCC) were preferentially activated during
fMRI when subjects were presented with self-relevant material, regardless of positive
versus negative valence. A prior fMRI study also found peak mPFC activity when all
subjects without psychological disease made self-referential judgements versus
answering general semantic knowledge questions.20 While Johnson’s study (2002)
showed statistically significant mPFC activity with regards to self-relevant knowledge
(p=0.05), Moran’s (2004) study extended those findings when subjects showed greater
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mPFC activity specifically with traits that were akin to their own personality, possibly
indicating increased self-referential thought or focus. Increased self-focus is a core
feature in the pathology of MDD according to cognitive theory, and it has been shown to
extend and worsen the severity of depressive episodes by perpetuating depressed thought
and mood.21,17,22
2.4.2 The Neurobiology of the Default Mode Network
The Default Mode Network (DMN) is defined as a network of brain regions that
show coherent activity during a resting state and increased activity when individuals are
focused on their internal state, such as self-referential thought.23 Shulman and colleagues
(1997) first established the presence of the DMN in a meta-analysis of 9 PET-scan
studies, which demonstrated an interconnected resting state network with task activity
attenuation.
Over many subsequent studies, the DMN has been established to be involved in
many neurological disorders including major depressive disorder.24-27 Relevant to the
proposed study, Gusnard and colleagues (2001) found that in healthy subjects, the medial
prefrontal regions were preferentially associated with an increase in neural activity during
internally cued conditions.28 As a result, these regions must play a large role in
introspection. The anatomical and functional network of the DMN was further mapped in
a series of eloquent studies undertaken by Andrews-Hanna and colleagues using
functional connectivity MRI (fcMRI).29
In an initial experiment, the authors found evidence for two distinct sub-networks
working in a cohesive manner and interacting with a core region.29 These two networks
were termed the dorsal medial prefrontal cortex (dMPFC) subsystem and the medial
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temporal lobe (MTL) subsystem, distinct and separate as they had a correlation of near
zero. The anterior medial prefrontal cortex (amPFC) and PCC were found to make up the
common core of the DMN as they both showed the highest betweenness-centrality as
defined by their statistically significant activity correlations (p<0.001).30 In the second
experiment, regions within the dMPFC subsystem were selectively active in the PresentSelf condition, while the MTL subsystem showed much higher engagement in the FutureSelf condition. The PCC-amPFC core region demonstrated strong activation during both
present and future-self conditions, serving as a thorough way for the two subsystems.
Therefore, the dMPFC focuses on the current, present mental state of one’s self and
others, while the MTL subsystem focuses on future related self-reference, and the core
allows for coordination of both systems.
2.4.3 Major Depressive Disorder and the Default Mode Network
Elevated DMN functional connectivity (FC) has been shown to be a reliable
neural marker of MDD.25,31 On baseline imaging, depressed subjects exhibit the unique
finding of DMN hyper-connectivity.26,27 A meta-analysis compiled 27 studies analyzing
neurological activity using resting state functional connectivity MRI (rsfcMRI).27 The
brains of depressed patients had significant hyperconnectivity within the DMN.
Interestingly, there was a greater likelihood of hyperconnectivity in unmedicated MDD
patients between the DMN seeds and the hippocampus (likelihood ratio=6.01, p=0.09).
This suggests that higher activity within the DMN reflects greater severity of depressive
symptoms. These findings support the neurocognitive model in which brain network
dysfunction is highly correlated to a persistent, negative mood such as in MDD.

20

One of the largest, multi site fMRI studies on MDD used a dynamic networkbased approach, evaluating the resting state fMRI data from 460 patients with DSM-IV
criteria of MDD and a HAM-D17 score  8.32 Following ANCOVA, the PCC and mPFC
showed significant alteration in activity compared to healthy controls. This increase in
activity was consistent with prior studies, which suggest a relationship between aberrant
FC in the DMN and self-reflective, ruminative thinking contributing to depression
severity.27,33 Rumination is a core feature of depression and consists of persistent,
internally directed thought.21 Our proposed study will investigate not only baseline
activity of the DMN in depressed individuals, but also following additional interventions
to see if that baseline hyperactivity is modifiable.
A review paper discussed whether observing change in DMN FC can serve as an
effective tool for depression diagnosis and lead to more successful interventions.34 All the
studies considered consistently emphasized the DMN as a key factor contributing to
MDD and its relationship with depressive symptoms like rumination and excessive selfreferential thought. Another early fMRI study demonstrated that individuals with MDD
had an elevated resting state subgenual cingulate and DMN FC while resting quietly as
compared to health controls.35 Within group correlational independent component
analysis (ICA) demonstrated enhanced subgenual FC associated with greater lengths of
depressive episodes, reinforcing a possible relationship between brain FC and severity of
psychological disease. Our study will expand upon these findings by analyzing fMRI
scans with change in depression symptoms following interventions.
Researchers quantified resting state connectivity within three distinct resting state
brain networks, including the DMN, in unmedicated patients with MDD (HAM-D17 
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18) compared to non-depressed controls (HAM-D17  7).36 Patients suffering from
depression had enhanced connectivity within the DMN and ANCOVA analysis using sex,
age and education as covariates and did not contribute to the model despite significant
between-group differences. This study once again implicated increased resting-state
DMN FC as indicative of more self-focused thinking and strengthened the potential to
use FC as a marker for depression severity both before and after treatment, as in our
planned study.
2.4.4 Rumination and the Default Mode Network
Depressive rumination is defined as a persistent, self-reflective, and unintended
focus on depressive distress symptoms, causes and outcomes. It is reliably associated
with MDD with both adaptive and maladaptive components.21,37 The extent of rumination
is even predictive of future depressive symptoms over time and risk of relapse.38,39 A
narrative review of 94 studies of resting state brain network function in MDD found that
the DMN reliably showed connectivity alterations when compared to individuals without
mood disorders.40
Berman and colleagues used seed-based fMRI analysis with the PCC and mPFC
to evaluate rumination and the strength of association with DMN.41 Again, DMN
connectivity with those brain regions was related to rumination (p < 0.005). To rule out
possible contributions from the depressive subscoring used in the Ruminative Responses
Scale (RRS), focused analysis of connectivity scores from the brooding component of the
RRS still resulted in a positive relationship (r= 0.19, p < 0.05). The main effect of group
did not drive the correlation between RRS scores and PCC FC, just as it was when using
the two-sample t-tests for the functionally defined regions of interest. The study was
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strengthened through its consistent fMRI analytical protocol with two well established
core brain regions of the DMN.29
One meta-analysis of 14 studies explored the relationship between brain regions
and rumination within neuro-imaging studies, which was previously lacking.42 Prior
conclusions had been unclear, possibly due to inconsistency in sample sizes, various
demographic variables, and varied individual clinical features of subjects. What had been
clear throughout prior studies though was a unique relationship between rumination and
self-referential processing as signified through increased activity of cortical midline
structures in depressed individuals.43-45 The PCC and amPFC demonstrated highest
activation after rumination induction. Hyperactivation specifically within the DMN core
and dmPFC subsystem was associated with introspection and ruminative thought.46
This meta-analysis also helped to clarify the temporal aspect of ruminative
thoughts.42 The DMN core regions (amPFC and PCC) and dmPFC subsystem were
persistently activated when ruminating, while the MTL subsystem was not activated.
According to Andrews-Hanna (2010), the MTL subsystem is associated with
autobiographical recall while the dmPFC focuses on thinking about one or another
person’s current mentation. The findings support that rumination in depressed subjects
center negative thoughts regarding their own present mental states and environment
rather than the future. Therefore, mindfulness-based interventions which focus on the
present moment and associated emotions may be of benefit for those with MDD.
2.4.5 Other Associated Variables
Alterations in DMN FC are also present in those who are at high risk to develop
depression47,48 and are present in depressed individuals regardless of age.49,50 A study
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used fMRI to evaluate 111 individuals aged 11-60 years old at high and low familial risk
for depression, a part of a three-generational longitudinal cohort study of familial
depression that began in 1982.47 If first generation subjects did have MDD, then
subsequent generations were considered high risk. ICA showed that individuals at high
risk had increased DMN connectivity, especially within the PCC, precuneus, and mPFC.
Individuals at low risk showed no areas of increased activity within the DMN. In another
study, resting state FC MRI evaluated connectivity changes within first episode,
treatment naïve depressed individuals.48 Combined regional-wise FC analysis showed
aberrant connectivity between the mPFC and PCC. Both regions are associated with
aberrant executive control and emotion processing.51
Depression can also occur in the extremes of age. A case-control study examined
FC of 306 school aged children aged 8 years or older with a history of preschool onset
depression (PO-MDD).49 Using the PCC as seed region, rsfcMRI scans showed that
children with known PO-MDD had significantly increased connectivity between the PCC
and cortical midline regions such as the mPFC. This study replicated findings from other
studies in adults with MDD.36,41,42 A different study focused on a population of
unmedicated individuals aged 60 or older with MDD before and after escitalopram.52
There was no correlation between DMN FC and treatment response based on change in
MADRS scores. However, at baseline, late life depressed patients did exhibit heightened
FC within the DMN PCC seed region and the left precuneus. Across the ages, there is a
consistent, unique finding of increased resting state DMN FC within depressed
individuals. Our study incorporates DMN FC as a secondary outcome to evaluate
potential change through various interventions, pharmacological or otherwise.
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2.5 Nonpharmacological Interventions and the Default Mode Network

2.5.1 Sudarshan Kriya Yoga and Default Mode Network Functional
Connectivity
Despite a focused and exhaustive search on various databases, no articles were
found linking the DMN with SKY specific interventions.
2.5.2 Mindfulness Based Interventions and Default Mode Network Functional
Connectivity
As described previously, the DMN is a functionally distinct network of brain
regions with coherent activity at rest.26,29,53 The DMN has been associated with
attentional processes in the brain including fluctuations in attentional control, or mindwandering.54 Mind wandering, defined as interruption of focused thought with task
unrelated thought, is associated with and supported by the DMN.55 The DMN is also the
functional network associated with self-referential thinking. Self-referential thinking has
been defined as examining external stimuli as strongly related to oneself or persona, such
as evaluating the degree to which personality traits or certain words describe oneself.56-58
Interventions which aim at limiting mind wandering might lessen depressive
rumination over time. Mindfulness itself is characterized by self-regulated present
centered awareness.59 It is the key component in clinically applied MBSR which may
reduce mind wandering, as it brings the participant fully into the present moment.
A cross-sectional study investigated DMN activity in long term meditators versus
those who were meditation naïve following a mindful meditation (MM) intervention,
matching MBSR core tenants.54 There was markedly reduced functional connectivity in
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the PCC and mPFC seed regions in meditators versus controls (p < 0.05). Meditators also
subjectively reported less mind wandering experiences, which was associated with
lowered DMN activity. Mindfulness practices may specifically alter DMN activity and
thus should be evaluated clinically as a potential nonpharmacological avenue of treatment
for depression, as in this proposed study.60
2.5.3 Antidepressants and Default Mode Network Functional Connectivity
Recent studies utilizing antidepressants to treat MDD have evaluated treatment
efficacy not only subjectively based on depressive symptom severity, but also changes in
DMN activity. In a systemic review, 11 studies focused specifically on MDD and all
showed baseline DMN hyperconnectivity, which is in line with a recent metaanalysis.27,61 Within this review, an 8-week clinical trial assessed the effects of
escitalopram on emotion processing and regulation within moderate-severe MDD.62 A
repeated-measure ANOVA confirmed that MDD patients had increased amygdala
activation relative to HCs when anticipating negative stimuli. MDD individuals also
showed heightened prefrontal activation when passively viewing negative pictures which
was attenuated following antidepressant treatment, indicating that DMN FC is at least in
part modifiable. However, the aforementioned conclusion cannot be considered a causal
relationship because emotion regulation strategies were not assessed prior to this study.
Researchers studied the effect of a 12-week course of different antidepressants on
DMN FC in depressed individuals.63 Group ICA of imaging showed increased FC within
the two subnetworks of the DMN of depressed individuals, consistent with prior
studies.35,64 Researchers also found that increased DMN dominance was associated with
higher levels of maladaptive rumination and lower dominance with adaptive, reflective
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rumination.64 The mPFC hyperconnectivity persisted in recovered depressed individuals,
possibly relating to the high rate of relapse in depression given this persistent activity
despite antidepressant treatment with symptomatic improvement.
In a prospective, double blind, placebo-controlled trial, Posner and colleagues
evaluated duloxetine’s effect on DMN FC within individuals with dysthymic disorder
(DD) compared to placebo control group.65 Dysthymic disorder is differentiated from
MDD through experience of less severe depression symptoms for at least 2 years.
However, both disorders involve excessive rumination.39 Individuals with DD had at
baseline greater DMN connection density using the PCC as seed in whole brain resting
state FC maps. Post hoc analysis within DD individuals showed that they had a
statistically significant decrease in DMN connection density, so much so that it was at a
level comparable to healthy controls, indicating normalization of DMN connectivity.
Therefore, DMN FC could be used in future studies, such as this proposed RCT, as a
neural correlate to monitor progression of depression.
In the aforementioned study, there was no statistically significant relationship
found between normalization of DMN FC and reduction in depressive symptoms as
measured by the Hamilton Depression Rating Scale, 24 Item (HAMD-24). There is a
need for studies to further pursue this relationship between depressive symptoms and
DMN activity rigorously and specifically to assess for possible correlation, which is what
this proposed study hopes to contribute to.

2.6 Relevant Methodology
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This section of the literature review below details a review of studies concerning
relevant methodology used to validate our proposed study design, variables and outcome
measures. A detailed explanation of proposed study methods can be found in Chapter 3.
2.6.1 Study Design and Setting
The proposed study will be a prospective, randomized controlled trial (RCT)
primarily examining change in depression symptom severity in adult patients with mildmoderate MDD. Diagnosis will be based on self-rated and clinician rated questionnaires
comparing three randomized groups. An experimental treatment group will participate in
SKY, which is our primary exposure, along with continuation of their standard
antidepressant regimen. A second adjunctive care group will use MBSR and their
standard antidepressant treatment. Lastly, the standard care control group will continue
antidepressant medications only. As a secondary aim, we will use resting state functional
connectivity MRI (rsfcMRI) to determine changes in functional connectivity (FC) in the
DMN both within and between the three participant groups.
RCTs are considered the gold standard for clinical research as the use of
randomization eliminates potential bias inherent to other study designs. The prospective
nature of this study enables researchers to analyze a causal relationship between
interventions and outcomes. We chose not to use waitlist or placebo as our control
condition in this study. It would be unethical to require MDD patients to stop
antidepressants given the risk of discontinuation syndrome. Continuing a stable dose of
antidepressants also reduces the risk of rebound phenomenon, where patients experience
either higher rates of relapse or especially severe episodes of relapse following
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discontinuation.66 Therefore, our control group will continue their antidepressants at a
stable dose without any adjunctive treatment.
Although antidepressant medications in combination with nonpharmacological
therapy are recommended as first line for MDD, our study seeks to investigate whether
additional interventions- SKY and MBSR- will be beneficial. We will take potential
confounders into consideration, such as sex, age, and education level.67-69 The equipoise
principle of RCTs is fulfilled, as each group holds equal potential for depression severity
reduction without superiority.70 We seek to find effective and tolerable adjunctive
treatments in addition to pharmacological therapy that promote improved rates of
response and ultimate remission of depressive symptoms.
The study will recruit patients from the Yale University Undergraduate and
Graduate campuses as well as specialty community outpatient clinics such as the
Connecticut Mental Health Center and the Cornell Scott-Hill Health Center. These sites
were chosen in order to reach a broader selection of participants with diverse
socioeconomic, ethnic, and health care access backgrounds.
Participants will be recruited through flyer callouts, posted throughout Yale
University Undergraduate and Graduate campuses to advertise to the university student
population (See Appendix D). These recruitment flyers will also be posted at outpatient
clinics to engage the community, specifically the Connecticut Mental Health Center, as
well as the Cornell Scott-Hill Health Center. This does have the potential limitation of
selection bias, as it includes mainly patients who are highly motivated and already
connected to care at these clinics. However, this select group of patients are most able to
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benefit from the proposed interventions as they require high compliance, and thus this
limitation is acceptable.
2.6.2 Selection of Interventions
Given the high rate of recurrence of depressive symptoms despite adequate
pharmacological treatment with or without psychotherapy, this study will focus on two
adjunctive treatments to pharmacotherapy when treating MDD: Sudarshan Kriya Yoga
(SKY) and Mindfulness Based Stress Reduction (MBSR).
2.6.2A Sudarshan Kriya Yoga
SKY was chosen as our primary intervention because it has been the most widely
used breathwork in clinical studies and research.1 SKY reliably consists of three different
types of breathing: three stage Ujjayi or victory breathing, Bhastrika or bellows
breathing, and Sudarshan Kriya or cyclical breathing. The four components of SKYthree stage slow ujjayi, bhastrika, “om” chanting, and Sudarshan Kriya- are performed
with the eyes closed while sitting in a cross legged position, and breathing in and out
through the nostrils (see Appendix A for SKY Breathwork Components).4,71 Subjects
within our proposed study will be taught the three components of SKY without yoga
asanas or physical postures, om chanting, stretching, or meditation.72 This will be done in
order to isolate the antidepressant effects of breathwork specifically.
Within our literature review, there were deviations with the timing, frequency and
duration of SKY as well as inconsistent incorporation of mindfulness, stress reduction
tools, and yoga postures.1-4,73 For example, one RCT solely focused on the three types of
SKY breathing without any other mindfulness component over a duration of four weeks,
with daily 30-minute sessions led by an Art of Living Foundation instructor for six days
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per week.1 Hamilton-West and colleagues (2019) incorporated SKY with mindfulness,
stress relieving skills, and meditation.2 The study period was four weeks, similar to
Janakiramah’s protocol (2000), but differed in frequency of sessions. A certified SKY
instructor led four, one-hour sessions per week, with one weekend 2.5 hour workshop and
four weekly 90 minute individual sessions for personalized feedback for all participants.
Another clinical trial taught SKY breathwork, om chanting, and mindfulness
skills in addition to holding weekly self-help groups within a period of two weeks, but
extended follow-up to six months.3 There were ten, two-hour long instructor-led sessions
for the initial two weeks, then weekly follow-up two hour sessions held for six months of
follow-up. Participants were also expected to perform individual breathwork and
mindfulness practices six days per week for an average duration of 20 minutes, which is
similar to the randomized waitlist-controlled study performed by Sharma and colleagues.4
In addition to private at-home practice, the study included yoga, mindfulness meditation,
stress education and SKY breathwork for six 3.5-hour sessions during the first week of
the study. Weeks 2 through 6 consisted of daily 1.5 hours of SKY training in addition to
individual practice. Lastly, an open label study shortened the duration of SKY
breathwork, self-reflection, meditation, yoga stretches, and stress coping strategies into
an intensive 5-day period.73 The first day consisted of 3 hours of instruction in the three
main forms of breathwork, which was continued onto Day 2 alongside adjunctive
strategies for 6.5 hours. The last few days consisted of a total of 10 hours of training, with
home practice introduced on Day 5 for 20 minutes per day for 6 days per week. This
assortment of SKY protocols illustrates a lack of standardization and thus a limiting
factor in the existing literature.
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The inconsistency in SKY protocol is a limiting factor in the literature with no
superior format determined. For this reason, we chose to match the well tolerated and
uniform MBSR protocol to our SKY protocol. This decision will allow for equivalence in
exposure to both interventions, and highlight what MBSR lacks, which is a breathwork
component.
2.6.2B Mindfulness Based Stress Reduction
MBSR was chosen as our mindfulness-based intervention (MBI) specifically
because it has been the most widely studied MBI and has clinically proven high patient
tolerability and compliance rates.5,74 Originally used to treat chronic pain, MBSR has
been applied to psychological and behavioral disorders with good effect.75
Typically, the course is set up as an 8-week program with one instructor-led 2.5
hour session per week. In each group session containing up to 30 people, participants are
instructed on mindfulness meditation skills. While lying down with eyes closed during
the body scan practice, participants focus attention on sensation from head to toe. This
mindset is then maintained in sitting meditation.6 Lastly, Hatha yoga consists of gentle
body awareness brought about through physical movement and stretching. Outside of one
weekly group meeting, individuals will complete a daily 45-minute mindfulness practice
for six days per week. Audiotapes will be used early on but gradually tapered in use.
This standardized MBSR protocol described above was then applied to treatment
of generalized anxiety and panic disorders fulfilling DSM-III criteria.76 A repeated
measures analysis of variance (ANOVA) showed highly significant reduction in anxiety
and depression from pre to post treatment. The high rate of completion (92%) and
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maintenance of practice in 90% of patients at 3-month follow-up was encouraging for
future studies utilizing MBIs.
Baer and colleagues conducted a review of 22 studies using MBSR and MBCT
for chronic pain and Axis-I disorders including depression relapse.5 Post treatment effect
sizes ranged from 0.15 to 1.65, with an overall independent mean effect size of 0.74 (SD=
 0.39). Mean completion rate was 85% which demonstrated the high tolerability of
MBIs. In future studies, adequate sample sizes will be needed to assure medium to large
effect size. Furthermore, the studies rarely reported how they ensured treatment
completion. Our study will incorporate a daily log sheet for patients to record their
sessions, and individual instructor feedback will help bolster treatment integrity (See
Appendix E for Daily Log Sheet).
Kabat-Zinn conducted the most extensive meta-analysis of MBSR program
completion over a two-year period assessing 1,155 patients.74 Researchers measured
completion rate and found that 76% of patients completed the eight-week intervention in
totality with a 15% drop out rate. This meta-analysis revealed MBSR to be an effective
with high patient compliance within a variety of somatic and psychological disorders.
In this planned study, MBSR became the choice intervention for our mindfulness
active control arm due to various studies demonstrating high rates of compliance,
program completion and patient satisfaction. While a large portion of this study’s MBSR
protocol will parallel the original established by Kabat Zinn75, our study will have one
key differentiating factor: an online format. A meta-analysis analyzing the effectiveness
of 15 RCTs using either websites or live virtual classrooms for MBIs in place of face-toface MBIs showed improvements in depression with a small significant effect size.13 A
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pre-planned schedule with password protected links will be sent out to the MBSR as well
as SKY group at the start of the study. Weekly live sessions will be scheduled in the
evening hours to allow for participants’ occupational or educational commitments to be
met first. Given the prevalence of COVID-19, necessitating social distancing to reduce
exposure and spread of the virus, this adjustment in MBSR protocol is both necessary and
just.
The MBSR intervention will carry on for a period of eight weeks in total,
matching the standard MBSR methodology. There will be one 2.5 hour session each
week led by an instructor virtually with up to 30 people per group, who will teach three
core mindfulness skills: full body scan, sitting meditation, and Hatha yoga. Individual
individual practice is expected for 45 minutes per day, six days per week. Participants
will have access to pre-recorded instructor guidance sent out via email. As is typical in
MBSR programs, subjects will be encouraged to taper use of these audio recordings
halfway through the intervention period. There is a one time, online 7.5 hour intensive
workshop during the sixth week, with various days available for scheduling flexibility.
2.6.3 Primary Outcome Measures
The primary outcome measure of this proposed study is mean change in the 17Item Hamilton Depression Rating Scale (HAM-D17) total score from baseline to post
treatment at 8 weeks. A secondary questionnaire, the Beck Depression Inventory, Second
Edition (BDI-II), will also be given at the same time points. The use of an objective,
clinician rated score with a subjective, patient rated score will give greater legitimacy and
validity to changes in depression severity due to this combined assessment of two
perspectives.
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The HAM-D17 is considered the gold standard in outcome measures within
depression trials.77 The following scores will be used to differentiate depression severity:
no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe
depression (24).78 Response will be defined as a reduction of  50% of HAM-D17 score
obtained prior to treatment initiation, and remission will be a HAM-D17 score as  7.79
The BDI-II is a self-report questionnaire consisting of 21 items that is one of the
most commonly used tools to evaluate depression symptom severity.80 Importantly, all
questions are based on DSM-IV diagnostic criteria for MDD and measured with a 4-point
Likert scale.81 This measure has also demonstrated good internal consistency (= 0.91)
and validated psychometric properties.80 According to the BDI-II, the following scores
will be used to delineate depression severity: minimal depression (0-13); mild depression
(14-19); moderate depression (20-28); and severe depression (29-63).
2.6.4 Secondary Outcome Measure
The secondary outcome measure will be change in FC within the DMN,
interpreted through seed-based analysis of resting state functional connectivity MRI
(rsfcMRI). RsfcMRI evaluates functional connectivity within predefined brain regions by
correlating low frequency blood oxygenation level dependent (BOLD) signal changes
(<0.1 Hz) temporally. Scans will be performed at baseline prior to intervention and
following completion. All subjects will undergo a 5-minute fMRI scan while resting
quietly, given no specific instruction except to close their eyes and remain still, letting
their minds wander freely. The time period and specific wording of instructions is most
consistent with studies using rsfcMRI to evaluate the DMN.35,54,63-65
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Brain activity can be measured through structural, effective or functional
connectivity.82 Functional connectivity is defined as temporal associations of
synchronous neural activity between anatomically separate brain regions either at rest or
during a task.51,83 The DMN is notably most active at rest without any stimuli present.26,23
Therefore, resting state functional connectivity MRI (rsfcMRI) will be used rather than
task-based fMRI.84
Seed based analysis serves as a widely used method with easy interpretability for
measuring FC. The average measurement of the time series within a seed region is
linearly correlated with all other voxels, creating a seed-based functional connectivity
map.85 A drawback when using seed-based analysis rather than independent component
analysis (ICA) or graph theory is that areas of interest are restricted to predefined brain
regions only. In our proposed study, this definition dependence is a strength as we are
interested in a seed region integral to the DMN: the posterior cingulate cortex (PCC).
The PCC is the most reliable region shown to reveal FC within the DMN.51,86 In
our study, we will use an a priori seed voxel within the PCC (x= −8, y= −56, z= 26)
based on the Montreal Neurological Institute coordinates. This specific area was decided
upon after an extensive review of prior fMRI studies also focusing on the DMN within a
mood disorder patient population. Additionally, it is anatomically similar to the seed
regions that other researchers have used to define the DMN.26,31,41,51,54,65,87,88
All fMRI scans will be obtained at baseline and post intervention at the
conclusion of Week 8 on the same Siemens 3-Tesla whole body scanner at the Yale
Magnetic Resonance Research Center. Patients will be instructed to lie in the scanner
awake without stimuli and not think of anything in particular while their eyes are
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closed.83 A Velcro strap placed over the forehead will reduce head motion artifact.
Cardiac and respiratory physiologic noise will be monitored through a
photoplethysmography on a finger of the left hand and a pneumatic belt positioned at the
level of the upper abdomen.
Functional MRI data will be obtained through a T*2 weighted gradient-recalled
echo spiral pulse sequence with the following standardized parameters: repetition time/
echo time= 2000 msec/30 msec, flip angle= 80, 1 interleave, field of view= 200 x 200
mm2, matrix= 64 x 64, slices= 28.35 These parameters were chosen because they mirror
the same 5-minute interval of our resting state fMRI scan. We chose to use T*2 imaging
rather than T*1 imaging because there is higher temporal resolution and greater
sensitivity to blood flow and oxygenation in T*2 imaging.85
Following imaging, physiologic noise will be removed through pre-processing
prior to analysis. Measures of FC are highly dependent on the quality of BOLD signal.
The signal can become distorted through artifact, such as cardiac and respiratory cycle
noise.89,90 A type I error can occur if the noise components correlate with enough strength
to reach threshold, yet there is no neuronal correlation. Conversely, a type II error can
occur when there is actual temporal synchronization between the seed ROI and other
voxels which is not found due to overlying physiologic noise.91 Pre-processing will
consist of standard steps including slice-timing correction, motion correction,
normalization, spatial smoothing, and linear trend removal.
2.6.5 Confounders
Sex, age and education are potential confounders which threaten internal validity,
and therefore must be taken into account in order to avoid type I error.92
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Female predominance within depression studies reflects the core concept of
gender difference in depression.93 One meta-analysis found a 1.95 odds ratio for gender
differences in diagnosis of MDD. Furthermore, a proportion of studies and clinical trials
in our current literature review also demonstrated a predominance of women within
depressed populations.2-5,13,14,94 Within the same review, age was the strongest predictor
of effect size, with a peak of effect size in adolescence that stabilized in adulthood.
Initially, our RCT study design will reduce potential confounding effects via
randomization and creating groups that are adequately comparable in terms of potentially
confounding variables and size. In addition, analysis of covariance (ANCOVA) will be
applied to increase statistical power after data collection.

2.7 Conclusion
This current literature review demonstrates the unique application and potential
effectiveness of both SKY and MBSR as adjunctive antidepressant therapies, measured
through symptomatic relief and change in DMN FC through rsfcMRI. Depression affects
all age groups and is highly prevalent condition within the COVID-19 pandemic. We
have outlined areas for improvement within the current studies available concerning the
variables of this study, which our proposed study will address. Analysis of these studies
illustrated the components of our study design and the necessity of this study as we seek
to offer and expand current options for treatment of depression. Ultimately, this study
will add to the current literature focusing on non-pharmacological adjuvant treatment
options for mild to moderate depression.
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CHAPTER 3: STUDY METHODS

3.1 Study Design
We will conduct a prospective, randomized controlled trial (RCT) to determine if
there is a change in depression symptom severity and, secondarily, change in functional
connectivity in the Default Mode Network (DMN). The sample consists of adults with
mild to moderate major depressive disorder (MDD) aged 18 – 65 years old who are
randomized into one of three groups. The experimental treatment group will participate in
Sudarshan Kriya Yoga (SKY) as their adjunctive therapy in addition to their current
pharmacological regimen. An adjunctive care group will receive the established and
standardized Mindfulness Based Stress Reduction (MBSR) therapy in addition to their
current pharmacological regimen. A standard care group will continue to receive their
current pharmacological therapy. The goal is to examine change in symptoms of
depression within and between the three groups to investigate feasibility and efficacy of
adjunctive nonpharmacological treatments. Potential confounders, including sex, age, and
education, will be adjusted for in the study design and analysis.

3.2 Study Population and Sampling
The source population in this study is adults aged 18-65 years old with mild to
moderate depression, as defined by the diagnostic criteria as set forth by the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). From the pool of
subjects who respond to study recruitment efforts through an intake form, we will utilize
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convenience sampling based on meeting all inclusion criteria and no exclusion criteria
until an adequate sample size is reached during rolling enrollment. Once an adequate
sample size is reached, researchers will use online software to block randomize subjects
into each of the three study groups in order to have equal group size. (See Appendix F for
Intake Form).
3.2.1 Inclusion Criteria
Subjects will be adult outpatients aged 18-65 years old. All participants will be
assessed by a psychiatrist or clinical psychologist to meet criteria for mild-moderate
major depression (MDD), as the goal of the study is to investigate adjunctive,
nonpharmacological therapy in patients who continue to have symptoms of depression in
the mild-moderate range despite their current pharmacological regimen. The criteria for
inclusion are:
1) Current diagnosis of MDD for at least 2 years.
2) Fulfillment of criteria according to the Structured Clinical Interview for
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID for DSMIV) for a single or recurrent major depressive episode.
3) Have current self-reported mild-moderate depression symptoms within a total
score range of 8-23 for the 17-item Hamilton Depression Rating Scale (HAM-D17) and a
range of 14-28 for the Beck Depression Inventory, Second Edition (BDI-II).
4) All participants will need to be on a stable ( 8 weeks) dose of
antidepressant(s). If a pharmacological regimen is changed, participants can continue in
the study but may be removed from study analysis as appropriate.
5) Must be right-handed.
47

6) Must have access to a personal smart phone, computer, or tablet to access
remote online sessions.
3.2.2 Exclusion Criteria
The exclusion criteria for the selected study population includes any comorbid
Axis I disorders, bipolar disorder, psychosis, alcohol or substance abuse within the past 6
months, contraindications to MRI (e.g., metallic implants, pacemakers, or
claustrophobia), active suicidality, seizure disorder, history of head injury that resulted in
loss of consciousness, neurological disorder, brain degenerative disease, history of
electroconvulsive therapy, history of transcranial magnetic stimulation, history of stroke
or significant head injury, and current yoga, meditation or breathwork practices.

3.3 Recruitment
Participants will be recruited through IRB approved flyer callouts posted
throughout Yale University Undergraduate and Graduate campuses to advertise to the
university student population. Bulletin board advertisements will also be posted at
specialty outpatient clinics, including the Connecticut Mental Health Center and Cornell
Scott-Hill Health Center, to advertise to a more diverse clinical population and to offer
nonpharmacological, remote treatment options to the greater New Haven community. See
Appendix D for sample recruitment flyer.

3.4 Subject Protection and Confidentiality
This will be an Institutional Review Board (IRB)-approved, Health Insurance
Portability and Accountability Act (HIPAA)-compliant prospective randomized
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controlled trial. This study will obtain informed, written consent from each participant
that explicitly describes the group treatment sessions (See Appendix G). Participants will
be informed that during live remote video sessions for both MBSR and SKY, an
instructor will be teaching a group of less than 30 individuals. No sessions will ever be
recorded, and a password protected link will be sent out for each session. Participants
have the option of keeping their videos on in order to receive feedback. All members of
the research team will complete the Human Subjects Protection Training and HIPAA
Privacy training. No members will have external financial or non-financial interests
related to the research which may affect the protection of individuals volunteering for
research. Patient information will be protected through exclusive access on secure,
password encrypted institutional servers. Each participant will be given an ID code to
protect privacy. Participants will know explicitly what information will be used for
research purposes and be informed of our confidentiality and privacy practices.
Given that this study will be advertised within the undergraduate and graduate
Yale University campus grounds, all requirements will be fulfilled in accordance with
Yale IRB Policy 350 Participation of Yale Students, Fellows, Trainees, or Employees in
Research. Additionally, we will fulfill requirements when obtaining clear, informed
consent as set by the Yale IRB Policy 200 Informed Consent for Human Research. The
consent form will fully explain the purpose of this study and anticipated study duration,
emphasizing the group format of the study, identifying pertinent procedures with ensuing
comprehensive descriptions, and detailing the subject risk and benefits. The participants
will be made aware that participation is completely voluntary and that they can withdraw
at any point during the study without consequence. Contact information will be provided
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should subjects have any questions, comments or concerns. Final submission of the
necessary IRB forms will be made using the IRES IRB system.

3.5 Study Variables and Outcome Measures

3.5.1 Independent Variables
The independent variables in this study are SKY and MBSR as adjunctive
therapies to standard, stable dose antidepressant treatment for MDD. The mindfulness
intervention, MBSR, will be based on the original protocol developed by Kabat-Zinn,
with relatively minimal changes to adapt to an online context.1 Meditation sessions will
be led by a certified MBSR teacher conducted through live remote video. The
intervention duration will be for 8 weeks, weekly 2.5 hours group with less than 30
people per group. These sessions will be complemented with an independent at-home
practice approximately 45 minutes per day for 6 days per week, as well as a day-long
online mindfulness retreat on the sixth week of the intervention (9am-4pm). The SKY
protocol will mirror the MBSR administration. It will also be taught via live remote video
sessions, where once again participants have the option of turning their videos or
microphones on if desired in order to receive feedback from the instructor. A trained
SKY instructor from the Art of Living Foundation will lead participants through the main
SKY breathing techniques once per week for 2.5 hours, which is structurally equivalent
to the MBSR protocol. Participants will perform breathwork independently 45 minutes
per day for 6 days per week, and also participate in an online day long retreat during the
sixth week consisting of intensive breathwork and individual feedback (9am-4pm). The

50

specific elements of both MBSR and SKY interventions have been described previously
in detail (see Chapter 2).
3.5.2 Primary Dependent Variable
The primary dependent variable is change in severity of depression symptoms, as
measured by the clinician-rated 17-Item Hamilton Depression Rating Scale (HAM-D17)
which controls for observation bias, and secondarily by the self-rated Beck Depression
Inventory, Second Edition (BDI-II). The questionnaires are completed at baseline (Week
0) and again at the end of the study (Week 8). The HAM-D17 will utilize the following
scoring: severe depression (≥24), moderate depression (17-23), mild depression (8-16),
and no depression (0-7).2 The BDI-II consists of 21 questions which are self-completed
and consistent with the DSM-IV criteria used to both diagnose and treat depression. The
following established scoring will be used: severe depression 29–63, moderate depression
20–28, mild depression 14–19, and minimal depression 0–13.3
3.5.3 Secondary Dependent Variable
The second aim of this study is to examine how the two adjuvant treatments- SKY
and MBSR- effect functional connectivity (FC) within the DMN, in comparison to
isolated standard pharmacological therapy. Therefore, the secondary outcome of interest
in this study will be change in FC of the DMN within each group as well as across all
three groups. Participants will undergo a 5-minute resting state functional connectivity
MRI (rsfcMRI) scan performed at Week 0 (baseline) and post assessment at the end of
Week 8 to assess for change over time on the same Siemens 3-Tesla whole-body MRI
scanner. Changes in functional connectivity within the DMN will be assessed using an a
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priori defined posterior cingulate cortex (PCC) (x=-8, y=-56, z=26) as primary seed
region of interest (ROI) for seed-based functional connectivity analysis.
3.5.4 Potential Confounding Variables
Possible confounding variables within this study include sex, age and education
level. An advantage of the block randomization RCT design is to minimize the effects of
possible confounding variables. However, as this cannot be guaranteed and confounders
may influence the results of the study, an analysis of covariance (ANCOVA) statistical
approach will be utilized to account for potential effects of these confounders.4

3.6 Methodology Considerations

3.6.1 Blinding
It is not possible to double-blind this proposed study, as explicit patient
participation in SKY and MSBR is required. However, there are other opportunities to
incorporate blinding methods into the study design and elements. For example, SKY and
MBSR instructors will only be exposed to people who are in their respective groups.
These teachers will not know the randomized data number assigned to each participant
nor will they be involved in data analysis. In addition, the clinician who is rating the
HAM-D17 questionnaire at the beginning and conclusion of the study will not know
which group the subject was randomized to and will not be involved in treatment
administration. Patients will also be informed to not tell the outcome assessor which
treatment they received.
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3.6.2 Assignment of Intervention
Following meeting the inclusion and none of the exclusion criteria, eligible
participants will be randomly assigned to either intervention group or continue their
stable antidepressant regimen. Block randomization will then be carried out to allow for
an equal number of subjects per group. The randomization software will be completed by
a computer specialist external to the study.

3.7 Data Collection
Methods for data collection include questionnaires, such as the HAM-D17 and
BDI-II, and neuroimaging data acquired from rsfcMRI scans. Initially, participants will
fill out an intake form that will obtain name, age, sex, race/ethnicity, birth date, highest
level of education achieved, and the type, frequency, and duration of antidepressant
medications that are being taken. Other considerations, including exclusion criteria, will
also be assessed through this intake form. All participants will undergo a standardized
psychiatric evaluation using the SCID for DSM-IV. They will complete the clinician
rated HAM-D17 as well as the self-administered BDI-II in order to get a convergence of
object and subjective perspectives. All subjects will also undergo rsfcMRI scans at the
baseline and conclusion of the study. These scans will be performed on the same Siemens
3-Tesla MRI scanner at the Yale Magnetic Resonance Research Center, which is in close
proximity to the academic campuses, medical centers, and community from which our
participants will be recruited from. Lastly, participant compliance with home practice will
be assessed based on self-completed participant log sheet records that will be collected at
the end of the study.
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3.8 Sample Size Calculation
The calculation for our sample size was performed using the G*Power version 3.1
with ANCOVA to compare change in pre-intervention and post-intervention HAM-D17
total scores given the confounders of sex, age, and education level. The reviewed
literature is typically powered based on the primary outcome measure to a significance
level of 5% and power of 80%, which our study will follow. We utilized a medium effect
size, consistent with the studies reviewed also using similar outcome measures.5-7 Our
sample size was initially calculated to be 196 participants. We do anticipate a 10% drop
out rate, which led to a sample size of 213 participants. Reasons for drop out will be
recorded and tracked to identify any patterns of drop out that could potentially impact
results.8 Our complete sample size calculation can be found in Appendix H.

3.9 Statistical Analysis
Intention to treat (ITT) analysis will be used to analyze results in this prospective
RCT. Initially, baseline demographic characteristics that are continuous or dichotomous
in nature, including sex, age, and education levels of all enrolled participants, will be
analyzed using a chi-squared test. A correlation matrix will illustrate the cross
correlations between demographic variables and depression ratings.
3.9.1 Primary Outcome
Mean total HAM-D17 and BDI-II scores with standard deviation will be obtained
from each of the three groups both pre and post intervention. Paired t-tests will be used to
assess significant difference in depression symptom severity within each group based on
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mean difference in total HAM-D17 scores as primary outcome, and each t-test will be
two-sided with a significance of p< 0.05. In order to assess significant change in
depression symptom severity based on HAM-D17 between the three groups postintervention, ANCOVA will be performed with group as between subject factor and
baseline subject characteristics of sex, age and education level as covariates. The same
procedure will be repeated for the BDI-II questionnaire mean total scores.
3.9.2 Secondary Outcome
Functional connectivity changes within the DMN using the posterior cingulate
cortex (PCC) as the seed region of interest (ROI) (x=-8, y=-56, z=26) will be analyzed
through seed-based analysis both within and between each of the three groups at baseline
(Week 0) and the conclusion of the study at the end of Week 8. We will obtain average
time series from within the seed region and use the Pearson correlation coefficient to
capture linear, temporally dependent BOLD signal changes that indirectly reflect
synchronized activity between the PCC and other brain regions.9 We will then ztransform all functional connectivities with a Fisher’s r-to-z transformation for normal
distribution. The resultant connectivity map will show all voxels that had a significant
time dependent neural activity correlation with the PCC and thus reflect the strength of
functional connectivity, with a false discovery rate of 0.05 (pFDR <0.05).10,11
Within group analysis will next be done by entering z-scores into a series of onesample t-tests in SPM 12, comparing baseline and post-intervention scans with a
significance threshold of p< 0.05 (FDR corrected) for each group. This will determine
cortical regions with statistically significant association with the PCC seed ROI within
each of the three groups of participants after treatment completion.
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Secondly, between group analysis of FC will be accomplished using ANCOVA
with group as between subject factor and sex, age and education level as covariates
(p<0.05, FDR corrected, minimum 21 voxels in a cluster). ANCOVA has the lowest
variance, highest power, and nominal 95% CI coverage relative to ANOVA-POST and
ANOVA-CHANGE, making it the preferred analytical tool.4
3.9.3 Image Pre-Processing
Images will be pre-processed using the Statistical Parametric Mapping Software,
Version 12 (SPM 12), including slice-timing correction using sinc interpolation, 3D
motion correction using sinc interpolation, normalization into the Montreal Neurological
Institute space, and spatial smoothing with a 3D Gaussian kernel (full-width-at-halfmaximum of 4 mm).10,12 These measures will suppress high frequency signals that reflect
spatial noise as well as enhance low frequency signals within the .01 Hz to .08 Hz range,
and lastly result in linear trend removal. Subjects who have excessive head motion
(>2.5mm translation or > 5 rotation) will be excluded from future analysis.12 The first
five images will be discarded to allow for magnetic equilibrium and discard magnetic
saturation.
Physiological noise from cardiorespiratory components will be monitored through
a photoplethysmography placed on the finger of the left hand and a pneumatic belt
positioned at the level of the upper abdomen. Cardiac and respiratory artifact will be
removed using the RETROICOR algorithm and by removing low-frequency respiratory
rate and heart rate effects.13,14

3.10 Timeline and Resources
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Pending IRB approval, the study will be completed within 2 years, encompassing
patient recruitment and protocol completion. After interested participants contact the
research team through an email which will be listed on all IRB approved flyers, an online
screening will be done to determine eligibility. Screen consists of an intake survey
detailing their name, age, gender, level of education, psychological disorders, frequency
and dosage of any antidepressant medications, and exclusion criteria (See Appendix F for
Intake Form). A clinical psychologist or psychiatrist will administer the SCID for DSMIV and the patient will complete the BDI-II. We will use a rolling enrollment period of 12
months or until the calculated sample size of 213 is reached. Following signature of an
informed consent form upon enrollment, participants will be block randomized into one
of three groups: pharmacological therapy with SKY, pharmacological therapy with
MBSR, or continuing standard pharmacological therapy without adjunctive therapy
(serving as control). All adults will be educated on the use of password protected links for
either MBSR or SKY, as well as given flexible time slots to obtain baseline fMRI
imaging. Data analysis will be completed within 2-3 months following completion.
Personnel to be included in this study include a principal investigator, a coprincipal investigator, clinical psychologist or psychiatrist to rate baseline and post
intervention HAM-D17 questionnaires, a computer specialist to randomize eligible
subjects, Yale Magnetic Resonance Research center lab assistant to run rsfcMRI scans,
fMRI imaging analyst, a certified SKY instructor, and a certified MBSR instructor. There
will also be one physician associate student to aid in recruitment, data analysis, and
statistical analysis.
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CHAPTER 4: CONCLUSION

4.1 Advantages
When reflecting on our study’s advantages, the prospective, randomized
controlled trial (RCT) design reduces bias through randomization. The most relevant
strength of the experimental intervention of this study- Sudarshan Kriya Yoga (SKY)lies in the fact that breathwork is both an economically sound and socially just practice.
SKY could be used to stabilize a patient’s current treatment, decreasing the number of
prescriptions which enable financial savings.1,2
This practice can be used on a multitude of patients, including those with physical
disability. It is easy to administer across urban, suburban, and rural regions given the
online format of the intervention. Once the basic cadence of breathwork is memorized,
then the patient can proceed at leisure in terms of deciding when to practice, with no need
to travel anywhere, take time off work, or find childcare.
The study design will establish a potential standardized SKY protocol, as the
current literature reviewed by researchers was inconsistent. Furthermore, matching the
SKY protocol to the well-established and tolerated Mindfulness Based Stress Reduction
(MBSR) protocol will allow for equivalence in the exposure to the interventions in our
study. The design is also feasible for future studies due to its online format. No in-person
MBSR or SKY sessions will be required, allowing participants to complete their assigned
intervention in the comfort of their own homes. In addition, focusing specifically on
depression during the COVID-19 pandemic is especially pertinent given rising isolation
and prevalence of depression.3 Increased prevalence of depression may persist while
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COVID-19 health and safety policies remain, which highlights the relevance of an at
home, easy to use, individual practice like SKY.

4.2 Disadvantages
Although this study contains significant advantages in terms of study design and
contribution to the current literature, there are some limitations. Convenience sampling is
nonrandomized, resulting in potential selection bias and lower external validity.
Furthermore, the target patient population was specified to those mild-moderate
depression already on antidepressant medications within the Yale Health System and
greater Connecticut areas. This study was designed to exclude severely depressed
patients because they are often refractory to typical treatment and require escalation to
high intensity therapies.4 Our study may have lower external validity, as the patient
population is not completely representative of the entire population of depressed
individuals. However, if this intervention is found to be successful in the selected mildmoderate population, we would think carefully about how this intervention could be
assessed safely in a population with severe depression, such as in an inpatient setting.
The study protocol will control for physiologic noise during rsfcMRI scans through a
photoplethysmography and pneumatic belt. However, it does not control for participant
related factors that could have affected BOLD signal. The vasoconstrictive effect of
caffeine affects cerebral blood flow which in turn alters BOLD signal.5 Aside from
caffeine, intake of food, nicotine, and alcohol before a resting state fMRI scan can have
significant effects on BOLD signal. Given that MRI times will be scheduled throughout
the day, the researchers did not want to be overly restrictive to a vulnerable population.
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Lastly, treatment adherence is a common threat to MBI effectiveness.6,7. Nonadherence occurs when participants do not complete the intervention in entirety with the
minimum frequency as defined in study protocol. Regular practice is essential to obtain
ultimate benefit.8 Although the study participants will complete a self-reported daily log,
it might be more accurate to have researcher personnel observed SKY or MBSR sessions
to ensure completeness and accuracy. Future studies without the current social distancing
requirements and COVID-19 health and safety conditions could implement therapists to
observe or lead individual practice sessions.

4.3 Clinical Significance
This study is clinically significant because it examines the effectiveness of an
adjunctive treatment for MDD and can broaden our understanding of the underlying
mechanisms amongst breath-oriented therapy, depression, and functional connectivity
within the brain. If this study demonstrates effectiveness and high patient tolerability with
SKY, breathwork could become more widely accessible for patients, especially those
undergoing financial hardship and already at risk for health disparities. Instead of
increasing dosage of antidepressants, SKY could be added as a low risk, low cost
adjunctive treatment to work in conjunction with the medications. In conclusion,
improving availability of treatment options and programs for individuals with mild to
moderate depression can reduce escalation of treatment, reduce relapse rates, and result in
greater rates of remission.9 This study has the potential to improve treatment options for
those with MDD through a cost effective and individually empowering additional
remedy: breathwork.
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Appendix A: Sudarshan Kriya Yoga Breathwork Components
Practice

Breath Rate (cycles/min,
cpm)a
2-4 cpm
30-40 cpm

3-stage victory breathing
Bellows breathing/
Bhastrika
Sudarshan Kriya cyclical
8-180 cpm
breathing
Rest Period
N/A
a
Approximate range
b
Practice duration includes rest periods

Duration (minutes)b
7 minutes
3 minutes
10 minutes
5 minutes
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Appendix B: 17 Item Hamilton Depression Rating Scale (HAM-D 17)
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Appendix C: Beck Depression Inventory, Second Edition (BDI-II)
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Appendix D: Recruitment Flyer
Volunteers Needed for Participation in Research Study
We are investigating the incorporation of Sudarshan Kriya Yoga breathwork as well as
Mindfulness Based Stress Reduction in addition to antidepressants for treatment of mild
to moderate major depressive disorder.

Who can participate?
Adults aged 18-65 years old with a diagnosis of mild to moderate depression currently on
antidepressant medications.

What will be asked of you?
You will be asked to participate in an online, certified instructor led, randomized
additional treatment option- either Sudarshan Kriya Yoga breathwork or Mindfulness
Based Stress Reduction- or continue your current antidepressant medication for a period
of 8 weeks with daily practice sessions required. You will undergo an fMRI scan both
before and after the intervention, as well as participate in 2 surveys to determine change
in depression severity following completion of the study.

If you are interested in participating or have any
questions, please do not hesitate to contact us at:
203-XXX-XXXX or researchteam@yale.edu
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Appendix E: Daily Log Sheet
Week
Week 1
Week 2
Week 3
Week 4
Week 5
Week 6
Week 7
Week 8

Day 1

Day 2

Day 3
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Day 4

Day 5

Day 6

Appendix F: Intake Form
Name: _________________________
Participant ID code: ________
Date: __/__/____
Age: ___
Gender: Male
Female
Education:
o No high school diploma
o High school diploma
o Associate’s degree or 2 years of college
o Bachelor’s degree
o Master’s degree
o PhD or professional degree
When were you diagnosed with major depressive disorder?
o < 2 years ago
o > 2 years ago
Duration of current depressive episode
o < 1 week
o 1-2 weeks
o 2-3 weeks
o 3-4 weeks
o 1 month
o 2 months
o 3 months
o 4 months
o 5 months
o 6 months
Current antidepressant medications, dosages and duration:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Are you right-handed? Yes No
Do you have access to a personal smart phone, computer, or tablet? Yes No
Are you currently being treated for any other mood disorder?
Yes
No
- If “yes”, please write down which other disorder: ______________________________
Do you have Bipolar disorder?
Yes
No
Have you ever experienced psychosis?
Yes
No
Any excessive alcohol or substance use within the past 6 months?
Yes
No
Do you have any metallic implants or a pacemaker?
Yes
No
Are you claustrophobic?
Yes
No
Are you currently being managed for active suicidal thoughts?
Yes
No
Do you have a seizure disorder? Yes
No
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Any history of head injury or trauma that resulted in a loss of consciousness?
Yes
No
Do you have any neurological disorders?
Yes
No
Do you have a brain degenerative disease?
Yes
No
Have you undergone electroconvulsive therapy before or transcranial magnetic
stimulation?
Yes
No
Any history of stroke or significant head injury? Yes
No
Do you maintain a current yoga, breathwork, or meditative practice? Yes
No
------------------------------------------------------------------TO BE COMPLETED BY RESEARCHER:
HAM-D 17 total score, baseline: ________
BDI-II total score, baseline: __________
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Appendix G: Written Consent Form
WRITTEN CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT
Study Title: Sudarshan Kriya Yoga and Alteration in Depression Severity and Default
Mode Network Connectivity
Principal Investigator: Dr. Emily Sharp
Co-Principal Investigator: Elizabeth Togneri
Affiliation: Yale University School of Medicine, Connecticut Mental Health Center, &
Cornell Scott-Hill Health Center
Invitation to Participate and Description of Project
We are inviting you to participate in a research study designed to look at change in
depression severity and brain activity following three different interventions. You were
selected because you are currently undergoing pharmacological treatment for depression.
Approximately 213 individuals will participate in this study. Every individual will be
randomized to one of three groups: Sudarshan Kriya Yoga (SKY) breathwork alongside
antidepressants, Mindfulness Based Stress Reduction (MBSR) with antidepressants, or
only continuing antidepressants. Change depression symptom severity as well as brain
functional connectivity via fMRI scans will be compared amongst these groups after 8
weeks.
In order to decide whether or not you wish to be a part of this research study you should
know enough about its risks and benefits to make an informed decision. This permission
form gives you detailed information about the study, which a member of the research
team will discuss with you. This discussion should go over all aspects of this research: its
purpose, the procedures that will be performed, any risks of the procedures, and possible
benefits. Once you understand the study, you will be asked if you wish to participate; if
so, you will be asked to sign this form.
Description of Procedures
If you agree to participate in this study, you will be asked to undergo an fMRI scan both
prior to the start of the study and at the conclusion of the study at approximately 8 weeks.
After signing the consent form, you will be contacted by a researcher to complete two
surveys. One will be completed on your own time and is called the Beck Depression
Inventory, Second Edition. A second survey will be administered by a clinician who will
ask you a number of questions concerning your depression which is called the 17-Item
Hamilton Depression Rating Scale. Both surveys will be completed again at the
conclusion of the study.
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You will also be randomized into one of the three aforementioned groups. All group
participants will continue their current antidepressant regimen per usual. If you are
assigned to the first group, you will be instructed in basic breathwork skills according to
Sudarshan Kriya Yoga (SKY). If you are assigned to the second group, you will
participate in meditation sessions according to Mindfulness Based Stress Reduction
Protocol and also continue your antidepressant regimen. If you are assigned to the third
group, you will only continue your antidepressant medications. You will be sent a
confidential, password protected link to participate in online training for either group
which has an additional treatment, either breathwork or mindfulness skills.
If you are randomized to the Sudarshan Kriya Yoga group, you will have one 2.5 hour
session led by a certified instructor during Week 1 who will teach the basic breathwork
skills. You will then be expected to practice breathwork 45 minutes per day, six days
each week. Lastly, you will attend a 7.5 hour workshop during Week 6, also held online.
If you are assigned to the MBSR group, you will undergo the same time commitment as
above, but be taught by a different instructor who specifies in full body scan practice,
sitting meditation, and Hatha yoga.
The purpose of this survey is to evaluate whether nonpharmacological adjunctive
treatments can improve depression severity and alter functional connectivity in the brain.
If research results are published, your name and other personal information will not be
given.
Risks and Inconveniences
Magnetic resonance (MR) is a technique that uses magnetism and radio waves, not xrays, to take pictures and measure chemicals of different parts of the body. The United
States Food and Drug Administration (FDA) has set guidelines for magnet strength and
exposure to radio waves, and we carefully observe those guidelines.
You will be watched closely throughout the MR study. Some people may feel
uncomfortable or anxious. If this happens to you, you may ask to stop the study at any
time and we will take you out of the MR scanner. On rare occasions, some people might
feel dizzy, get an upset stomach, have a metallic taste or feel tingling sensations or
muscle twitches. These sensations usually go away quickly but please tell the research
staff if you have them.
There are some risks with an MR study for certain people. If you have a pacemaker or
some metal objects inside your body, you may not be in this study because the strong
magnets in the MR scanner might harm you. Another risk is the possibility of metal
objects being pulled into the magnet and hitting you. To lower this risk all people
involved with the study must remove all metal from their clothing and all metal objects
from their pockets. We also ask all people involved with the study to walk through a
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detector designed to detect metal objects. It is important to know that no metal can be
brought into the magnet room at any time. Also, once you are in the magnet, the door to
the room will be closed so that no one from outside accidentally goes near the magnet.
We want you to read and answer very carefully the questions on the MR Safety
Questionnaire related to your personal safety. Take a moment now to be sure that you
have read the MR Safety Questionnaire and be sure to tell us any information you think
might be important.
This MR study is for research purposes only and is not in any way a healthcare
examination of the brain. The scans performed in this study are not designed to find
abnormalities. The principal investigator, the lab, the MR technologist, and the Magnetic
Resonance Research Center are not qualified to interpret the MR scans and are not
responsible for providing a healthcare evaluation of the images. If a worrisome finding is
seen on your scan, a radiologist or another physician will be asked to review the relevant
images. Based on his or her recommendation (if any), the principal investigator or
consulting physician will contact you, inform you of the finding, and recommend that
you seek medical advice as a precautionary measure. The decision for additional
examination or treatment would lie only with you and your physician. The investigators,
the consulting physician, the Magnetic Resonance Research Center, and Yale University
are not responsible for any examination or treatment that you receive based on these
findings. The images collected in this study are not a healthcare MR exam and for that
reason, they will not be made available for healthcare purposes.
Recording daily MBSR meditation sessions and SKY breathwork sessions may come as
an inconvenience to you. Researchers will be available for questions at any time and
encourage your full participation.
You may be uncomfortable revealing personal information in participant surveys. Every
effort will be made to keep your information confidential. A breach of confidentiality is
unlikely to occur, as all study investigators are trained in research privacy.
Benefits
This study aims to evaluate whether depression severity can be further relieved by
supporting individuals through breathwork or mindfulness based tactics. There may be
direct benefit for you from participation in gaining a new skill and tool, whether it is
breathwork or stress reduction techniques, to help with depressive symptoms. Your
participation may also forward research to help many others also suffering from
depression to find effective, additional therapy options.
Treatment Alternatives/Alternatives
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Appropriate alternative options regarding therapy and diagnostic options include
speaking with your primary care provider or psychiatrist regarding current medication
dosages, as well as declining to participate in this study.
Confidentiality
We understand that information about your health is personal, and we are committed to
protecting the privacy of that information. Any identifiable information that is obtained in
connection with this study will remain confidential and will be disclosed only with your
permission or as required by U.S. or State Law. Examples of information that we are
legally required to disclose include abuse of a child or elderly person, or certain
reportable diseases. Information will be kept confidential by using identification
numbers on study forms, storing signed forms in locked cabinets and password protecting
data stored on a computer. When the results of the research are published or discussed in
conferences, no information will be included that would reveal your identity unless your
specific permission for this activity is obtained.
Representatives from the Yale Human Research Protection Program, the Yale Human
Investigation Committee (the committee that reviews, approves, and monitors research on
human subjects) may inspect study records during internal auditing procedures. However,
these individuals are required to keep all information confidential.
By signing this form, you authorize the use and/or disclosure of the information described
above for this research study. The purpose for the uses and disclosures you are
authorizing is to ensure that the information relating to this research is available to all
parties who may need it for research purposes.
All healthcare providers subject to HIPAA (Health Insurance Portability and
Accountability Act) are required to protect the privacy of your information. The research
staff at the Yale School of Medicine are required to comply with HIPAA and to ensure
the confidentiality of information.

Voluntary Participation and Withdrawal
Participating in this study is voluntary. You are free to choose not to take part in this
study. Refusing to participate will involve no penalty or loss of benefits to which you
are otherwise entitled (such as your health care outside the study, the payment for your
health care, and your health care benefits). However, you will not be able to enroll in this
research study and will not receive study procedures as a study participant if you do not
allow use of your information as part of this study.
Withdrawing From the Study
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If you do become a subject, you are free to stop and withdraw from this study at any time
during its course. This will cancel any future MRI appointments and evaluation of
depressive symptoms based on surveys. To withdraw from the study, you can call or
email a member of the research team at any time and tell them that you no longer want to
take part.
The researchers may withdraw you from participating in the research if necessary.
Withdrawing from the study will involve no penalty or loss of benefits to which you are
otherwise entitled. It will not harm your relationship with your own doctors or with the
Connecticut Mental Health Center and the Cornell Scott-Hill Health Center.
When you withdraw from the study, no new health information identifying you will be
gathered after that date. Information that has already been gathered may still be used and
given to others until the end of the research study, as necessary to insure the integrity of
the study and/or study oversight.
Questions
We have used some technical terms in this form. Please feel free to ask about anything
you don't understand and to consider this research and the consent form carefully – as long
as you feel is necessary – before you make a decision.
Authorization
I have read (or someone has read to me) this form and have decided to participate in the
project described above. Its general purposes, the particulars of my involvement and
possible hazards and inconveniences have been explained to my satisfaction. My signature
also indicates that I have received a copy of this consent form.
Name of Subject:_____________________________

Signature:___________________________________
Relationship:________________________________
Date:______________________________________
___________________________________________
Signature of Principal Investigator
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___________________
Date

or
___________________________________________
Signature of Person Obtaining Consent

___________________
Date

If you have further questions about this project or if you have a research-related problem,
you may contact the Co-Principal Investigator, Elizabeth Togneri.
If, after you have signed this form you have any questions about your privacy rights,
please contact the Yale Privacy Officer at 203-432-5919. If you would like to talk with
someone other than the researchers to discuss problems, concerns, and questions you may
have concerning this research, or to discuss your rights as a research subject, you may
contact the Yale Human Investigation Committee at (203) 785-4688.
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Appendix H: Sample Size calculation
The sample size was calculated* using the following parameters
Alpha= 0.05 (2-sided hypothesis)
Power= 0.80
Factoring in a 10% drop-out rate, the final sample size is 213, with 71 individuals per
group.

*Calculated using G*Power version 3.1 with ANCOVA
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